Omada Health’s CEO on IPOs, Amazon and GLP-1s
Omada Health CEO Sean Duffy talked about a potential initial public offering for the digital health company.
Related Articles
Man invests $12,000 in realistic dog costume to open unique animal experience
Toco, who became an internet sensation after claiming he wanted to live as a Border Collie, opened his own Tocotoco Zoo in Japan.
Revolutionizing Financial Services: UiPath’s AI-Driven Innovations Transforming Efficiency and Compliance
Podcast Episode · What’s Up with Tech? · 01/30/2025 · 16m
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
FBI Warns iPhone And Android Users—Stop Answering These Calls
You must heed this FBI warning—here’s what to know.
The Oncologist turns thirty
The Oncologist is completing its third decade bringing academic oncology to daily practice. When it was conceived by Marty and Ann Murphy with Bruce Chabne
Study Highlights Distinct Needs of Patients with Psoriasis, Skin of Color
This literature review points to a variety of research into differences in the diagnosis and treatment of patients with psoriasis and skin of color compared…
Are you problematic? This ‘cancel culture insurance’ could help you deal with social media backlash
Insurance agency Samphire Risk is reportedly rolling out a policy for celebrities and highly paid executives afraid of social media backlash.
Multidisciplinary Rehab Team Helps Patient Make Full Recovery From Severe Ski Accident
How neurorehabilitation at Cleveland Clinic London Hospital enabled a 34-year-old to fully recover from traumatic brain injury following devastating ski accident
Revolutionizing Global Customer Communication: Klearcom’s Innovative AI and Telephony Solutions Transforming the Telecom Landscape
Podcast Episode · What’s Up with Tech? · 01/30/2025 · 26m
Sam Altman’s $5.4B Nuclear Fusion Startup Helion Baffles Science Community
Helion’s nuclear fusion promises have garnered the attention of Silicon Valley—and raised concerns amongst scientists wary of its aggressive timeline.
